Pediatric Services OF America (NASDAQ:PSAI)
Historical Stock Chart
From May 2019 to May 2024
PSA HealthCare (Nasdaq:PSAI) announced today financial
results for fiscal year 2006.
Highlights of PSA’s results for the fourth
quarter and year ended September 30, 2006 include:
Three sequential quarters of staffing over 800,000 nursing hours;
Continued strong cash collections;
Year over year revenue growth of approximately 5%.
For the fourth quarter of fiscal 2006, net revenue from continuing
operations increased $1,568,000 to $31,896,000 as compared to
$30,328,000 in the third quarter of fiscal year 2006. Net loss from
continuing operations was $2,458,000 in the fourth quarter of fiscal
year 2006 as compared to a net loss from continuing operations of
$530,000 in the third quarter of fiscal year 2006. Net loss was
$1,279,000 in the fourth quarter of fiscal year 2006 as compared to net
income of $624,000 for the third quarter of fiscal year 2006. Basic and
diluted net loss per share was $0.17 in the fourth quarter as compared
to net income per share of $0.08 in the third quarter of fiscal year
2006. In the fourth quarter, the Company established an allowance of
$2,431,000 on the full value of the insurance recoveries receivable from
its former worker’s compensation insurance
carrier whose financial condition significantly deteriorated during the
quarter.
For the year ended September 30, 2006 net revenue from continuing
operations increased $5,214,000 to $119,360,000 as compared to
$114,146,000 in the year ended September 30, 2005. Net loss from
continuing operations was $6,196,000 in the year ended September 30,
2006 as compared to a net loss of $5,580,000 for the year ended
September 30, 2005. Continuing operations net loss per share was $0.84
in the year ended September 30, 2006 as compared to a net loss per share
of $0.77 in the year ended September 30, 2005. Basic and diluted net
income per share was $3.25 for the year ended September 30, 2006 which
included $3.33 for the gain on the sale of discontinued operations as
compared to net income per share of $0.79 for the year ended September
30, 2005.
“We are now solely focused on leveraging our
core competency in pediatric nursing via our PDN and PPEC operations,”
said Daniel J. Kohl, President and CEO of PSA HealthCare. "Our fiscal
2006 was highlighted by the monetization of the Pharmacy segment’s
assets and subsequent monetization of the RTES segment’s
assets in the first quarter of fiscal 2007 for total consideration of
$107.4 million. These transactions have enabled us to build a cash
balance in excess of $70 million to utilize as growth capital for
acquisitions and start-up activities. Additionally, our focused business
model greatly aided our ability to achieve a full-year record of 3.3
million nursing hours staffed.”
Conference Call
A conference call to discuss these results has been scheduled for
Tuesday, December 12, 2006 at 11:00 a.m. ET. The
dial-in number for all Participants is 800-374-1702. Note: To
join the Q&A session, please press the asterisk followed by 1. If you
are unable to listen to the live broadcast, replays of the conference
call will be available until December 26, 2006 by dialing 800-642-1687.
To connect with the replay of the conference call, please refer to the
PSA HealthCare Earnings Call, Passcode: 3807069 #.
PSA provides comprehensive pediatric home health care services through a
network of over 54 branch offices in 18 states, including satellite
offices and branch office start-ups. Through these offices, PSA provides
a combination of services, including pediatric private duty nursing
(PDN), and pediatric day treatment centers (PPECs). Additional
information on PSA may be found on the Company's website at http://www.psahealthcare.com.
NOTE: This press release contains certain forward-looking
statements (as such term is defined in the Private Securities Litigation
Reform Act of 1995) relating to future financial performance of PSA
Healthcare (the “Company”).
When used in this press release, the words “may,”
“targets,”
“goal,” “will,”
“could,” “should,”
“would,” “believe,”
“feel,” “expects,”
“confident,” “anticipate,”
“estimate,” “intend,”
“plan,” “potential”
and similar expressions may be indicative of forward-looking statements.
These statements by their nature involve substantial risks and
uncertainties, certain of which are beyond the Company’s
control. The Company cautions that various factors, including the
factors described hereunder and those discussed in the Company’s
other filings with the Securities and Exchange Commission, as well as
general economic conditions, industry trends, the Company's
anticipated uses of the proceeds from the sale of its Pharmacy and RTES
Businesses, the integration of the Melmedica acquisition, assimilate
and manage previously acquired field operations, collect accounts
receivable, including receivables related to acquired businesses and
receivables under appeal, hire and retain qualified personnel and comply
with and respond to billing requirements issues, including those related
to the Company’s billing and collection
system, nurse shortages, competitive bidding, HIPAA regulations, adverse
litigation, workers’ compensation losses,
availability and cost of medical malpractice insurance and reduced state
funding levels and nursing hours authorized by Medicaid programs, could
cause actual results or outcomes to differ materially from those
expressed in any forward-looking statements of the Company made by or on
behalf of the Company. Any forward-looking statement speaks only
as of the date on which such statement is made, and the Company
undertakes no obligation to update any forward-looking statement or
statements to reflect events or circumstances after the date on which
such statement is made or to reflect the occurrence of an unanticipated
event. New factors emerge from time to time, and it is not
possible for management to predict all of such factors. Further,
management cannot assess the impact of each such factor on the business
or the extent to which any factor, or combination of factors, may cause
actual results to differ materially from those contained in any
forward-looking statements.
PSA HEALTHCARE
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In Thousands, Except Per Share Data)
Twelve Months Ended
September
30,
September 30,
2006
2005
Net revenue
$
119,360
$
114,146
Costs and expenses:
Costs of goods and services
(exclusive of depreciation
shown separately below)
72,560
68,195
Other operating costs and expenses
Administrative and marketing salaries, wages and benefits
19,927
19,537
Business insurance
4,766
4,165
Overhead
7,571
6,983
Other operating costs and expenses
32,264
30,685
Corporate, general and administrative
Salaries, wages and benefits
14,211
14,128
Business insurance
255
208
Professional services
3,816
4,476
Overhead
2,781
2,880
Corporate, general and administrative
21,063
21,692
Provision for doubtful accounts
126
679
Provision for insurance recoveries
2,431
-
Depreciation and amortization
1,032
997
Total costs and expenses
129,476
122,248
Operating loss
(10,116)
(8,102)
Interest income
2,248
212
Interest expense
(564)
(2,481)
Loss on early extinguishment of debt
(837)
-
Other income
54
65
Loss from continuing operations before income tax benefit
(9,215)
(10,306)
Income tax benefit
(3,019)
(4,726)
Loss from continuing operations
(6,196)
(5,580)
Discontinued operations:
Income from discontinued operations before income tax expense
9,194
18,320
Income tax expense
3,591
7,074
Income from discontinued operations
5,603
11,246
Gain on disposal of discontinued operations before income tax expense
40,562
-
Income tax expense
15,844
-
Gain on disposal of discontinued operations
24,718
-
Net income
$
24,125
$
5,666
Income per share data:
Basic net income per share data:
Loss from continuing operations
$
(0.84)
$
(0.77)
Income from discontinued operations
0.76
1.56
Gain on disposal of discontinued operations
3.33
-
Net income
$
3.25
$
0.79
Diluted net income per share data:
Loss from continuing operations
$
(0.84)
$
(0.77)
Income from discontinued operations
0.76
1.56
Gain on disposal of discontinued operations
3.33
-
Net income
$
3.25
$
0.79
Weighted average shares outstanding:
Basic
7,413
7,203
Diluted
7,413
7,203
CONDENSED CONSOLIDATED BALANCE SHEET INFORMATION
September
30,
2006
September 30,
2005
Cash and cash equivalents
$48,848
$19,036
Accounts receivable, less allowance for doubtful accounts
17,705
14,941
Total stockholders' equity
101,432
73,569
PSA HEALTHCARE
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In Thousands, Except Per Share Data)
Three Months Ended
September 30,
June 30,
2006
2006
Net revenue
$
31,896
$ 30,328
Costs and expenses:
Costs of goods and services (exclusive of depreciation shown
separately below)
19,743
18,395
Other operating costs and expenses
Administrative and marketing salaries, wages and benefits
5,057
5,159
Business insurance
945
1,217
Overhead
1,991
1,881
Other operating costs and expenses
7,993
8,257
Corporate, general and administrative
Salaries, wages and benefits
3,616
3,516
Business insurance
64
68
Professional services
1,094
784
Overhead
641
746
Corporate, general and administrative
5,415
5,114
Provision for doubtful accounts
64
(3)
Provision for insurance recoveries
2,431
-
Depreciation and amortization
286
258
Total costs and expenses
35,932
32,021
Operating loss
(4,036)
(1,693)
Other income
-
46
Interest income
581
656
Loss from continuing operations before income tax benefit
(3,455)
(991)
Income tax benefit
(997)
(461)
Loss from continuing operations
(2,458)
(530)
Discontinued operations:
Income from discontinued operations before income tax expense
1,815
1,905
Income tax expense
699
747
Income from discontinued operations
1,116
1,158
Gain on disposal of discontinued operations before income tax
(benefit) expense
-
Income tax (benefit) expense
(63)
4
Gain on disposal of discontinued operations
63
(4)
Net income
$
(1,279)
$ 624
Income per share data:
Basic net income per share data:
Loss from continuing operations
$
(0.33)
$ (0.07)
Income from discontinued operations
0.15
0.15
Gain on disposal of discontinued operations
0.01
(0.00)
Net income
$
(0.17)
$ 0.08
Diluted net income per share data:
Loss from continuing operations
$
(0.33)
$ (0.07)
Income from discontinued operations
0.15
0.15
Gain on disposal of discontinued operations
0.01
(0.00)
Net income
$
(0.17)
$ 0.08
Weighted average shares outstanding:
Basic
7,521
7,492
Diluted
7,521
7,492
CONDENSED CONSOLIDATED BALANCE SHEET INFORMATION
September 30, 2006
June 30, 2006
Cash and cash equivalents
$
48,848
$
53,116
Accounts receivable, less allowance for doubtful accounts
17,705
16,804
Total stockholders' equity
101,432
102,264
Nursing
PPEC
Consolidated Total
Twelve Months Ended September 30, 2006
Net revenue
$
108,406
$
10,954
$
119,360
Costs of goods and services (exclusive of depreciation shown
separately below)
Nursing and therapist salaries, wages, benefits and supplies
71,908
563
72,471
Disposables/Supplies
49
40
89
Total cost of goods and services
71,957
603
72,560
Other operating costs and expenses
Administrative and marketing salaries, wages and benefits
14,037
5,890
19,927
Business Insurance
4,375
391
4,766
Overhead
5,756
1,815
7,571
Total operating costs and expenses
24,168
8,096
32,264
Provision for doubtful accounts
151
(25)
126
Depreciation
178
202
380
Branch office contribution margin
$
11,952
$
2,078
$
14,030
Twelve Months Ended September 30, 2005
Net revenue
$
103,529
$
10,617
$
114,146
Costs of goods and services (exclusive of depreciation shown
separately below)
Nursing and therapist salaries, wages, benefits and supplies
67,544
576
68,120
Disposables/Supplies
43
32
75
Total cost of goods and services
67,587
608
68,195
Other operating costs and expenses
Administrative and marketing salaries, wages and benefits
13,812
5,725
19,537
Business Insurance
3,801
364
4,165
Overhead
5,355
1,628
6,983
Total operating costs and expenses
22,968
7,717
30,685
Provision for doubtful accounts
704
(25)
679
Depreciation
182
188
370
Branch office contribution margin
$
12,088
$
2,129
$
14,217
Twelve Months
Twelve Months
Ended
Ended
September 30,
September 30,
2006
2005
Total profit for reportable segments
$
14,030
$
14,217
Corporate, general and administrative
(21,063)
(21,692)
Corporate depreciation and amortization
(652)
(627)
Provision for insurance recoveries
(2,431)
-
Interest income
2,248
212
Interest expense
(564)
(2,481)
Loss on early extinguishment of debt
(837)
-
Other income
54
65
Loss from continuing operations, before income tax benefit
$
(9,215)
$
(10,306)
Nursing
PPEC
Consolidated Total
Three Months Ended September 30, 2006
Net revenue
$
29,045
$
2,851
$
31,896
Costs of goods and services (exclusive of depreciation shown
separately below)
Nursing and therapist salaries, wages, benefits and supplies
19,567
156
19,723
Pharmacy product and supplies
-
-
-
Disposables/Supplies
13
7
20
Total cost of goods and services
19,580
163
19,743
Other operating costs and expenses
Administrative and marketing salaries, wages and benefits
3,618
1,439
5,057
Business Insurance
858
87
945
Overhead
1,478
513
1,991
Total operating costs and expenses
5,954
2,039
7,993
Provision for doubtful accounts
24
40
64
Depreciation
55
65
120
Branch office contribution margin
$
3,432
$
544
$
3,976
Three Months Ended June 30, 2006
Net revenue
$
27,582
$
2,746
$
30,328
Costs of goods and services (exclusive of depreciation shown
separately below)
Nursing and therapist salaries, wages, benefits and supplies
18,228
145
18,373
Pharmacy product and supplies
-
-
-
Disposables/Supplies
12
10
22
Total cost of goods and services
18,240
155
18,395
Other operating costs and expenses
Administrative and marketing salaries, wages and benefits
3,631
1,528
5,159
Business Insurance
1,112
105
1,217
Overhead
1,444
437
1,881
Total operating costs and expenses
6,187
2,070
8,257
Provision for doubtful accounts
59
(62)
(3)
Depreciation
45
46
91
Branch office contribution margin
$
3,051
$
537
$
3,588
Three Months
Three Months
Ended
Ended
September 30,
June 30,
2006
2006
Total profit for reportable segments
$
3,976
$
3,588
Corporate, general and administrative
(5,415)
(5,114)
Corporate depreciation and amortization
(166)
(167)
Provision for insurance recoveries
(2,431)
-
Other income
-
46
Interest income
581
656
Loss from continuing operations, before income tax benefit
$
(3,455)
$
(991)